Dr. Messina discusses the role cytokine imbalance plays in the development of eczema and atopic dermatitis.
Dr. Rob discusses current psoriasis treatments and why new therapies are still needed.
Dr. Francis reviews his research on disease remission and biologics.
Dr. Gordon discusses how medication can be used to conceptualize and modify psoriasis.
Under the title, What’s Next in Psoriasis? From Maintenance to Disease Modification, the 2022 IPC Think Tank scientific symposium was
Recurrent flares, painful fiery-red skin, and sterile pustules — are the characteristics of Generalized Pustular Psoriasis (GPP), a rare and
Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients worldwide face barriers to
Psoriasis and tuberculosis have long gone hand-in-hand. This is especially true in certain parts of the world, where latent tuberculosis
Experts worldwide report on their experiences and deliver insight into the latest results and clinical studies. The following congress report
Biologics: Modification Strategies Marc Bourcier, MD, FRCPC, FAAD | Canada 2021https://www.youtube.com/watch?v=RQVf0PQP1c0
